Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 9 (September)

1. Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer.
   Gastroenterology, 131(3): 900-10. [Abstract] [Full-text]
2. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
   Cancer Chemother Pharmacol, 58(6): 771-5. [Abstract] [Full-text]
3. Accumulation of beta-catenin protein, mutations in exon-3 of the beta-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas.
   J Surg Oncol, 94(5): 418-25. [Abstract] [Full-text]
4. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer.
   J Surg Oncol, 94(5): 392-5. [Abstract] [Full-text]
5. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
   J Clin Oncol, 24(27): 4441-7. [Abstract] [Full-text]
6. MRI of adenocarcinoma of the pancreas.
   AJR Am J Roentgenol, 187(4): W365-74. [Abstract] [Full-text]
7. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness.
   Surg Endosc, 20(10): 1587-93. [Abstract] [Full-text]
8. Solid and pseudopapillary tumor of the pancreas--review and new insights into pathogenesis.
   Am J Surg Pathol, 30(10): 1243-9. [Abstract] [Full-text]
9. The clear cell variant of solid pseudopapillary tumor of the pancreas: a previously unrecognized pancreatic neoplasm.
   Am J Surg Pathol, 30(10): 1237-42. [Abstract] [Full-text]
10. An unusual case of undifferentiated carcinoma in situ with osteoclast-like giant cells of the pancreas.
    Pancreas, 33(3): 304-10. [Abstract] [Full-text]
11. Clinicopathologic features of two rare cases of mesenchymal metastatic tumors in the pancreas: review of the literature.
    Pancreas, 33(3): 301-3. [Abstract] [Full-text]
12. Clinicopathologic study on pancreatic groove carcinoma.
    Pancreas, 33(3): 255-9. [Abstract] [Full-text]
13. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
    Pancreas, 33(3): 250-4. [Abstract] [Full-text]
14. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection.
    Pancreas, 33(3): 246-9. [Abstract] [Full-text]
15. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
    Pancreas, 33(3): 240-5. [Abstract] [Full-text]
16. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma.
    Pancreas, 33(3): 233-9. [Abstract] [Full-text]
17. Pancreatic imaging: current and emerging technologies.
    Pancreas, 33(3): 211-20. [Abstract] [Full-text]
18. A family history of pancreatic cancer.
    Nat Clin Pract Gastroenterol Hepatol, 3(10): 586-91. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.